Zobrazeno 1 - 10
of 18
pro vyhledávání: '"S A, Cullinan"'
Autor:
S A Cullinan, James E. Krook, Michael J. O'Connell, Loren K. Tschetter, Harry S. Wieand, Charles G. Moertel, James A. Mailliard, Michael A. Poon
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 12(2)
PURPOSE The purpose of this study was to evaluate the therapeutic effectiveness of fluorouracil (5-FU), doxorubicin, and methyl lomustine (CCNU) (FAMe), 5-FU, doxorubicin, and cisplatin (FAP), and FAMe alternating with triazinate (TZT) when compared
Autor:
J N, Ingle, D I, Twito, D J, Schaid, S A, Cullinan, J E, Krook, J A, Mailliard, L K, Tschetter, H J, Long, J G, Gerstner, H E, Windschitl
Publikováno v:
Cancer. 67(4)
A randomized trial was performed to determine if therapy with tamoxifen (TAM) plus fluoxymesterone (FLU) was more efficacious than TAM alone for postmenopausal women with metastatic breast cancer. Patients failing TAM could subsequently receive FLU.
Autor:
L Ebbert, S A Cullinan, Edward T. Creagan, Michael H. Veeder, Roscoe F. Morton, James A. Mailliard, Chang Mn
Publikováno v:
Journal of Clinical Oncology. 5:1078-1082
We conducted parallel phase II trials of cimetidine as a single agent and the combination N-phosphonacetyl-L-aspartate (PALA) plus L-alanosine among 40 previously untreated patients with biopsy-proven, measurable disseminated malignant melanoma. We d
Autor:
James E. Krook, S A Cullinan, Robert F. Marschke, L K Everson, John A. Laurie, D J Klaassen, Charles G. Moertel, T R Buroker, James A. Mailliard, Thomas R. Fleming
Publikováno v:
Journal of Clinical Oncology. 3:1624-1631
Three hundred thirty-five previously untreated patients with advanced colorectal carcinoma were randomly assigned to treatment with 5-fluorouracil (5-FU) alone, 5-FU plus N-(phosphonacetyl)-L-aspartic acid (PALA), 5-FU plus high-dose thymidine, 5-FU
Autor:
S. A. Cullinan
Publikováno v:
JAMA: The Journal of the American Medical Association. 253:2061-2067
Autor:
C G Moertel, S A Cullinan
Publikováno v:
Journal of Clinical Oncology. 3:887-889
Autor:
J N, Ingle, L K, Everson, H S, Wieand, S A, Cullinan, L E, Wold, J B, Hagen, J K, Martin, J E, Krook, R G, Fitzgibbons, J F, Foley
Publikováno v:
Cancer. 63(7)
A randomized clinical trial was performed to determine if the addition of hormonal therapy with tamoxifen to a combination chemotherapy regimen was superior to the chemotherapy alone for adjuvant treatment of premenopausal women after mastectomy for
Autor:
J H, Edmonson, J E, Krook, J F, Hilton, H J, Long, S A, Cullinan, L K, Everson, G D, Malkasian
Publikováno v:
Cancer treatment reports. 70(8)
Between May 1980 and November 1983, 46 eligible patients with advanced, objectively evaluable endometrial carcinoma were treated with tamoxifen, 10 mg twice daily. Twenty-two of the patients had previously received progestational agents. None of the
Publikováno v:
Cancer. 51(11)
A 67-year-old woman with lymphoma presented with a neuromyopathy following "laetrile" (amygdalin) treatment. She had significant elevation of blood and urinary thiocyanate and cyanide levels. Sural nerve biopsy specimen revealed a mixed pattern of de
Autor:
James E. Krook, Robert F. Marschke, James N. Ingle, S A Cullinan, D I Twito, Daniel J. Schaid, James G. Gerstner, Harry J. Long, James A. Mailliard, H E Windschitl
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 6(5)
A randomized clinical trial was performed to determine if combination hormonal therapy with tamoxifen (TAM) and fluoxymesterone (FLU) was more efficacious than TAM alone for the treatment of postmenopausal women with metastatic breast cancer. Patient